Large-scale testing (Phase 3)Active Not RecruitingNCT05883644
What this trial is testing
Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)
Who this might be right for
Advanced Hepatocellular Carcinoma
AstraZeneca 111